Vikas V Dukhande Selected Research

Vikas V Dukhande Research Topics

Disease

7	Neoplasms (Cancer) 01/2022 - 01/2019
5	Lafora Disease 01/2021 - 01/2011
3	Neuroblastoma 01/2021 - 11/2006
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2015 - 10/2011
3	Astrocytoma (Pilocytic Astrocytoma) 10/2010 - 11/2006
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2019
2	Melanoma (Melanoma, Malignant) 07/2021 - 10/2019
2	Mitochondrial Diseases (Mitochondrial Disease) 06/2013 - 11/2007
1	Epilepsy (Aura) 01/2021
1	Hemolysis 01/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2021
1	Rare Diseases (Rare Disease) 01/2021
1	Inflammation (Inflammations) 01/2020
1	Necrosis 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Lung Neoplasms (Lung Cancer) 11/2019
1	Carcinogenesis 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 04/2014
1	Hypoxia (Hypoxemia) 11/2011
1	Body Weight (Weight, Body) 11/2011
1	Birth Weight (Birth Weights) 11/2011

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2007
4	GlycogenIBA 11/2019 - 04/2014
3	ARV-825IBA 01/2022 - 01/2020
3	Dual-Specificity PhosphatasesIBA 04/2014 - 01/2011
3	EnzymesIBA 11/2011 - 11/2007
2	Proteolysis Targeting ChimeraIBA 01/2022 - 01/2020
2	VemurafenibIBA 07/2021 - 10/2019
2	Liposomes (Liposome)IBA 07/2021 - 01/2021
2	EstersIBA 01/2020 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 11/2011
2	Glutathione (Reduced Glutathione)IBA 06/2013 - 11/2006
1	snake venom protein C activatorIBA 01/2022
1	Asialoglycoprotein ReceptorIBA 01/2022
1	Galactose (Galactopyranose)FDA LinkGeneric 01/2022
1	nintedanibIBA 07/2021
1	1,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	1,2-dilinoleyloxy-3-dimethylaminopropaneIBA 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 01/2020
1	BenzimidazolesIBA 01/2020
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2020
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2020
1	TriazolesIBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	CytokinesIBA 01/2020
1	CaspasesIBA 01/2020
1	Histones (Histone)IBA 11/2019
1	EphA2 ReceptorIBA 10/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2019
1	Peptides (Polypeptides)IBA 10/2019
1	TOR Serine-Threonine KinasesIBA 11/2011
1	Sirolimus (Rapamycin)FDA Link 11/2011
1	AMP-Activated Protein KinasesIBA 10/2011
1	Ligases (Synthetase)IBA 10/2011
1	CarbohydratesIBA 01/2011
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2011
1	Citrate (si)-Synthase (Synthase, Citrate)IBA 10/2010
1	Malate Dehydrogenase (Dehydrogenase, Malate)IBA 10/2010
1	Silicon Dioxide (Silica)FDA LinkGeneric 10/2010
1	Mitochondrial DNA (mtDNA)IBA 11/2007
1	Ethidium (Ethidium Bromide)IBA 11/2007
1	AntioxidantsIBA 11/2007
1	ManganeseIBA 11/2006

Therapy/Procedure

5	Therapeutics 01/2022 - 06/2013